Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gut 2020-11, Vol.69 (11), p.1907-1912
Hauptverfasser:	Zeng, Georgia, Gill, Upkar S, Kennedy, Patrick T F
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Alanine Alanine transaminase Antigens Antiviral agents Carcinogenesis Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - epidemiology Carcinoma, Hepatocellular - virology Cell cycle Children Chronic infection Cirrhosis Comorbidity Coronavirus Infections - epidemiology Coronavirus Infections - prevention & control Coronaviruses COVID-19 Cross Infection - prevention & control Deoxyribonucleic acid Disease transmission DNA DNA damage Early Detection of Cancer - statistics & numerical data Female Gene silencing Genomic instability Genomics Global Health HBX protein Hepatitis B Hepatitis B e antigen Hepatitis B, Chronic - diagnosis Hepatitis B, Chronic - epidemiology hepatocellular carcinoma Hepatocytes Humans Immune clearance Immune response Incidence Infections Integration Leading Leading article Liver cancer Liver cirrhosis Liver diseases Liver Neoplasms - diagnosis Liver Neoplasms - epidemiology Liver Neoplasms - virology Male Metabolic syndrome Middle Aged Mortality Pandemics Pandemics - prevention & control Pandemics - statistics & numerical data Pneumonia, Viral - epidemiology Pneumonia, Viral - prevention & control Prognosis Prophylaxis Risk factors Seroconversion Severe acute respiratory syndrome coronavirus 2 Surveillance Survival Analysis Tumor suppressor genes Tumors Ultrasonic imaging Vaccination Viruses World Health Organization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0017-5749 1468-3288
DOI:	10.1136/gutjnl-2020-321627